In vitro antibacterial activity of the synthesized derivatives (MIC: μg mL⁻¹).

Strain	Drug-sensitive bacteria				Drug-resistant bacteria
	S. aureus	B. subtilis	E. coli	P. aeruginosa	MRSA	K. pneumonia	VRE
5a	64	128	>128	>128	>128	>128	>128
5b	128	>128	>128	128	128	>128	>128
5c	128	64	128	128	>128	>128	>128
5d	128	128	>128	128	>128	>128	128
5e	32	64	128	128	>128	>128	>128
5f	32	64	128	>128	128	128	128
5g	32	32	64	>128	64	>128	>128
5h	64	128	128	128	128	>128	128
5i	64	64	128	>128	>128	128	128
5j	128	64	>128	128	128	64	128
5k	64	64	128	128	>128	>128	>128
5l	>128	>128	>128	>128	>128	>128	>128
5m	16	32	32	64	32	64	>128
5n	16	16	32	128	16	64	>128
5o	8	32	16	64	16	64	128
5p	4	8	4	64	8	128	>128
KAN a	1	0.5	1	4	1	4	8

^aKAN: kanamycin.